EN
HI
Aarti Drugs share price chart
Aarti Drugs Share Key Metrics
Volume
1.11 L
Market Cap
3763.97 CR
LTQ@LTP
10@412.40
ATP
412.11
Var Margin
17.37 %
Circuit Range
331.25-496.85
Delivery %
51.75 %
Value
4.56 CR
ASM/GSM
No
Market Lot
1
Summary
AARTIDRUGS stock price is ₹412.4 as of 5 Aug, 2026. The stock intraday movement has stayed between ₹408.80 and ₹415.95, while Aarti Drugs share price 52 week high low is ₹318.95 & ₹534.55.
In terms of trading activity, AARTIDRUGS share price has recorded a volume of 1,10,719 shares. The Aarti Drugs has a market cap of ₹91270000. The stock’s Average Traded Price (ATP) stands at ₹412.11, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹412.40.
The Aarti Drugs upper circuit limit is ₹496.85 & The Aarti Drugs lower circuit limit is ₹331.25, with a Value of ₹4.56 CR. The Delivery Percentage for the day is 51.75%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Aarti Drugs Fundamentals
P/E Ratio
19.78
P/B Ratio
2.36
Div. Yield
0.48
Sector P/E
64.89
Sector P/B
3.24
Sec. Div. Yield
0.52
Aarti Drugs Resistance and Support
Pivot 413.1
Resistance
First Resistance
418.95
Second Resistance
423.85
Third Resistance
429.7
Support
First Support
408.2
Second Support
402.35
Third Support
397.45
Aarti Drugs Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Aug 05 2026 | 414 | 412.4 | -0.40% | 415.95 | 408.8 |
| Tue Aug 04 2026 | 411 | 414.04 | 1.67% | 418 | 407.25 |
| Mon Aug 03 2026 | 424 | 407.25 | -3.67% | 424 | 405 |
Aarti Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-15 | Audited Results |
| 2026-02-03 | Quarterly Results & Interim Dividend |
| 2025-11-07 | Quarterly Results |
| 2025-07-18 | Quarterly Results |
| 2025-05-06 | Audited Results |
| 2025-01-29 | Quarterly Results & Interim Dividend |
| 2024-10-24 | Quarterly Results |
| 2024-08-26 | Buy Back of Shares |
| 2024-07-26 | Quarterly Results |
Aarti Drugs News
Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
The audio recording of the investor/analyst conference call regarding the financial results for the quarter ended June 30, 2026, has been uploaded to the company's website. The transcript will also be made available in due course.
Aug 03 2026 19:24:54
Aarti Drugs Ltd - 524348 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Aarti Drugs reported Q1 FY27 revenue of Rs.703.6 crore, an increase of 19% YoY. The company's adjusted net profit grew 29% YoY, reflecting strong operational performance.
Aug 01 2026 17:16:54
Read More
Aarti Drugs Management
| Name | Position |
|---|---|
| Rushikesh Deole | Company Secretary & Compliance Officer |
| Chandrakant V Gogri | Chairman Emeritus |
Aarti Drugs Similar Stocks
Artemis Medicare Services Ltd.
322.15
20.40 (6.76%)
RPG Life Sciences Ltd.
2707.80
-37.90 (1.38%)
IOL Chemicals And Pharmaceuticals Ltd.
163.41
9.67 (6.29%)
Gufic Biosciences Ltd.
394.35
-2.70 (0.68%)
Indraprastha Medical Corporation Ltd.
368.30
-2.15 (0.58%)
Advanced Enzyme Technologies Ltd.
332.75
10.10 (3.13%)
Unichem Laboratories Ltd.
497.40
-2.90 (0.58%)
SMS Pharmaceuticals Ltd.
364.55
1.05 (0.29%)
Gujarat Themis Biosyn Ltd.
355.95
2.25 (0.64%)
Morepen Laboratories Ltd.
76.95
7.77 (11.23%)
Aarti Drugs FAQs
The Buying Price of Aarti Drugs share is 412.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aarti Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aarti Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aarti Drugs shares is 19.78. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aarti Drugs shares is 2.36. Useful to assess the stock's value relative to its book value.
To assess Aarti Drugs’s valuation compare Sector P/E, P/B which are 64.89 & 3.24 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aarti Drugs is 3763.97 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aarti Drugs share price is 534.55 & 318.95. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aarti Drugs belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in AARTIDRUGS
Or Download Choice FinX App
Invest in AARTIDRUGS
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade